Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors
for Renal Cell Carcinoma (RCC)
44 locations incl. Phoenix
Sponsor: Exelixis
Sex: All·Age: 18+
Code: NCT05176483·Phase 1·Recruiting·Listed Jan 2022
Exelixis Clinical
Clinical research site in Durham, North Carolina · 3500 WESTGATE DR STE 900, DURHAM, NC 27707-2534 · (919) 891-3096
Part of Exelixis Clinical
As of July 2026, 1 paid clinical trial is recruiting at Exelixis Clinical in Durham, North Carolina. Active studies at this site cover conditions such as Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Urothelial Carcinoma (UC). Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Exelixis Clinical (1)
More research sites in Durham
- Duke University Medical Center (273 trials)
- Duke University (194 trials)
- Duke University Hospital (55 trials)
- Duke University Health System (47 trials)
- Duke Cancer Institute (39 trials)
- Durham VA Medical Center, Durham, NC (30 trials)
- Duke Cancer Center (28 trials)
- Durham VA Medical Center (16 trials)
- Duke University School of Medicine (13 trials)
- Duke Eye Center (12 trials)
Explore more
Paid clinical trials in Durham, NC · North Carolina clinical trials